entrectinib

FDA Approval of Roche Cancer Drug Confirms Beginning of New Oncology Era
Motley Fool
Wed, 09/11/19 - 12:46 pm
Roche
FDA
entrectinib
cancer
Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
Fri, 07/26/19 - 11:04 am
FDA
AbbVie
upadacatinib
Roche
Ignyta
entrectinib
Kala Pharmaceuticals
KPI-121
dry eye disease
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
ASCO 2019
Merck
AstraZeneca
pancreatic cancer
Novartis
alpelisib
Roche
entrectinib
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Fri, 05/17/19 - 10:05 am
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
As generic competition stutter sales of top oncology drugs, Roche secures speedy review for pair of experimental cancer offerings
Endpoints
Tue, 02/19/19 - 12:15 pm
Roche
Seattle Genetics
generics
antibody-drug conjugate
polatuzumab vedotin
relapsed or refractory diffuse large B-cell lymphoma
entrectinib
solid tumors
Loxo's targeted therapy holds up to Roche challenge
Biopharma Dive
Sun, 10/21/18 - 11:36 pm
Roche
entrectinib
Loxo Oncology
Ignyta
Bayer
larotrectinib
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Xconomy
Mon, 09/24/18 - 03:32 pm
Roche
entrectinib
Ignyta
FDA
non-small cell lung cancer
Hunting an early FDA OK, Ignyta surges on promising snapshot of lung cancer data
Endpoints
Wed, 10/18/17 - 09:24 am
Ignyta
entrectinib
non-small cell lung cancer